Next Article in Journal
Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain
Next Article in Special Issue
Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
Previous Article in Journal
Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
Previous Article in Special Issue
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(10), 2080; https://doi.org/10.3390/pharmaceutics14102080
Action Date Notes Link
article xml file uploaded 29 September 2022 14:00 CEST Original file -
article xml uploaded. 29 September 2022 14:00 CEST Update -
article pdf uploaded. 29 September 2022 14:00 CEST Version of Record https://www.mdpi.com/1999-4923/14/10/2080/pdf-vor
article html file updated 29 September 2022 14:01 CEST Original file -
article xml file uploaded 3 October 2022 06:35 CEST Update -
article xml uploaded. 3 October 2022 06:35 CEST Update https://www.mdpi.com/1999-4923/14/10/2080/xml
article pdf uploaded. 3 October 2022 06:35 CEST Updated version of record https://www.mdpi.com/1999-4923/14/10/2080/pdf
article html file updated 3 October 2022 06:36 CEST Update -
article html file updated 28 February 2023 15:56 CET Update https://www.mdpi.com/1999-4923/14/10/2080/html
Back to TopTop